Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Mynd Life Sciences Inc (MYND.CN)

Mynd Life Sciences Inc (MYND.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 1,435
  • Shares Outstanding, K 47,817
  • Annual Sales, $ 0 K
  • Annual Income, $ -1,518 K
  • 60-Month Beta N/A
  • Price/Sales 1,425,665.39
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade MYND.CN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.02
  • Most Recent Earnings $-0.01 on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0200 +50.00%
on 04/12/24
0.0300 unch
on 04/19/24
unch (unch)
since 03/19/24
3-Month
0.0100 +200.00%
on 03/14/24
0.0400 -25.00%
on 03/15/24
-0.0050 (-14.29%)
since 01/19/24
52-Week
0.0050 +500.00%
on 10/20/23
0.1000 -70.00%
on 11/14/23
-0.0200 (-40.00%)
since 04/19/23

Most Recent Stories

More News
MYND Life Sciences Announces New Director & Update on the Proposed Merger with Cava Healthcare Inc.

Vancouver, British Columbia--(Newsfile Corp. - January 30, 2024) - MYND Life Sciences (CSE: MYND) (OTCQB: MYNDF) ("MYND" or the "Company") The Company is pleased to welcome Ms. Laurie Bakke who was recently...

MYNDF : 0.0227 (+15.82%)
MYND.CN : 0.0300 (unch)
MYND Life Sciences Inc. Announces the Appointment of Mr. John Campbell as President and Chief Executive Officer

Vancouver, British Columbia--(Newsfile Corp. - December 5, 2023) - MYND Life Sciences (CSE: MYND) (OTCQB: MYNDF) ("MYND" or the "Company"), a pioneering biopharmaceutical research and development company...

MYNDF : 0.0227 (+15.82%)
MYND.CN : 0.0300 (unch)
Dr. Lyle Oberg Appointment as Board Chair of Alberta Health Services and Executive Chair of MYND Life Sciences

Vancouver, British Columbia--(Newsfile Corp. - December 4, 2023) - MYND Life Sciences (CSE: MYND) (OTCQB: MYNDF) ("MYND" or the "Company"), We are delighted to announce the appointment of Mynd Life...

MYNDF : 0.0227 (+15.82%)
MYND.CN : 0.0300 (unch)
MYND Life Sciences Inc. Announces Non-Binding LOI to enable merger with Cava Healthcare Inc.

Potential merger to create new industry leader.Vancouver, British Columbia--(Newsfile Corp. - October 25, 2023) - MYND Life Sciences (CSE: MYND) (OTCQB: MYNDF) ("MYND" or the "Company"), a pioneering biopharmaceutical...

MYNDF : 0.0227 (+15.82%)
MYND.CN : 0.0300 (unch)
MYND Life Sciences Announces Update on Payment Obligations Under Unsecured Convertible Debentures

MYND Life Sciences was formed to commercialize proprietary biomarker diagnostic tests and novel therapeutics for patients suffering from MDD, TRD and other neuro-inflammatory disordersVancouver, British...

MYNDF : 0.0227 (+15.82%)
MYND.CN : 0.0300 (unch)
MYND Life Sciences Inc. Has Management CTO Revoked

Vancouver, British Columbia--(Newsfile Corp. - May 9, 2023) - MYND Life Sciences (CSE: MYND) (OTCQB: MYNDF) ("MYND" or the "Company"), a biopharmaceutical research and development company creating innovative...

MYNDF : 0.0227 (+15.82%)
MYND.CN : 0.0300 (unch)
MYND Life Sciences Inc. Provides Default Status Report

Vancouver, British Columbia--(Newsfile Corp. - April 25, 2023) - MYND Life Sciences (CSE: MYND) (OTCQB: MYNDF) ("MYND" or the "Company"), a biopharmaceutical research and development company creating innovative...

MYNDF : 0.0227 (+15.82%)
MYND.CN : 0.0300 (unch)
MYND Life Sciences Inc. Provides Default Status Report

Vancouver, British Columbia--(Newsfile Corp. - April 12, 2023) - MYND Life Sciences (CSE: MYND) (OTCQB: MYNDF) ("MYND" or the "Company"), a biopharmaceutical research and development company creating...

MYNDF : 0.0227 (+15.82%)
MYND.CN : 0.0300 (unch)
MYND Life Sciences Inc. Announces Non-Binding MOU with German Based Oxygen Handel and Provides Default Status Report

Global expansion as MYND executes non-binding MOU with German based Oxygen Handel.Vancouver, British Columbia--(Newsfile Corp. - March 29, 2023) - MYND Life Sciences (CSE: MYND) (OTCQB: MYNDF) ("MYND"...

MYNDF : 0.0227 (+15.82%)
MYND.CN : 0.0300 (unch)
MYND Life Sciences Inc. Achieves a Major Milestone and Provides Default Status Report

Identification of a potent, monomolecular non-hallucinogenic analog of psilocybin 100 times stronger than psilocybin.Vancouver, British Columbia--(Newsfile Corp. - March 14, 2023) - MYND Life Sciences...

MYNDF : 0.0227 (+15.82%)
MYND.CN : 0.0300 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 0.0300
2nd Resistance Point 0.0300
1st Resistance Point 0.0300
Last Price 0.0300
1st Support Level 0.0300
2nd Support Level 0.0300
3rd Support Level 0.0300

See More

52-Week High 0.1000
Fibonacci 61.8% 0.0637
Fibonacci 50% 0.0525
Fibonacci 38.2% 0.0413
Last Price 0.0300
52-Week Low 0.0050

See More

Business Summary

MYND Life Sciences Inc is a medical biotech drug research and development company. The company is focused on neuro pharmaceutical and novel drug development, diagnostics, and vaccines and is developing new biological entities (NBEs) and new chemical entities (NCEs) and differentiates itself from other...

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar